In a groundbreaking development in the understanding of Hirschsprung’s disease (HSCR), recent research has illuminated the complex molecular interplay involving circular RNAs (circRNAs) and their...
The University of Copenhagen proudly announces Immortal Dragons as a Tier 4 sponsor for the upcoming 12th Aging Research and Drug Discovery (ARDD) Meeting, scheduled...
In the relentless pursuit of advancing solar energy technologies, perovskite solar cells (PSCs) have emerged as a beacon of hope, promising an unprecedented combination of...
In the realm of emerging infectious diseases, arenaviruses have long posed a formidable challenge due to their ability to cause severe hemorrhagic fevers with high...
In a groundbreaking study that pushes the boundaries of neuroscience and psychiatric genetics, researchers have unveiled how the disrupted tempo of cortical neuron development may...
Pancreatic ductal adenocarcinoma (PDAC) stands as one of the deadliest malignancies globally, notorious for its aggressive invasiveness, late diagnosis, and grim prognosis. Representing the predominant...
The rapid advancement of artificial intelligence (AI), particularly generative AI, has ushered in a new era of innovation in healthcare communication. A notable and emerging...
In the face of increasing climate volatility and the aging condition of electrical grid infrastructure, the pursuit of enhanced energy affordability and resilience for households...
The University of Copenhagen proudly announces Mitra Bio as a Tier 3 Sponsor for the upcoming 12th Aging Research & Drug Discovery Meeting (ARDD 2025),...
In a groundbreaking study published in Nature Communications, researchers have unveiled alarming new evidence regarding the acquisition of highly drug-resistant Escherichia coli strains by hospitalized...
In the relentless march of urban expansion, one environmental challenge has persistently intensified: the urban heat island (UHI) effect. Characterized by elevated temperatures in urban...
A groundbreaking Phase 3 clinical trial, KEYNOTE-426, has delivered compelling evidence that a combination of pembrolizumab and axitinib significantly enhances long-term survival outcomes in patients...
Approximately 60% of U.S. households could achieve an average reduction in electricity costs of about 15% should they choose to invest in a solar-battery system....
A groundbreaking study conducted by researchers at the Ineos Oxford Institute for Antimicrobial Research (IOI) has uncovered alarming evidence regarding the rapid spread of antimicrobial...
In recent years, understanding the balance of life on Earth has become more critical than ever, with photosynthesis at the heart of this inquiry. Photosynthetic...
